| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.05▼ | 5.05▼ | 5.05▼ | 5.02▼ | 5.11▼ |
| MA10 | 5.04▼ | 5.04▼ | 5.03▼ | 5.03▼ | 5.14▼ |
| MA20 | 5.06▼ | 5.06▼ | 5.06▼ | 5.07▼ | 5.38▼ |
| MA50 | 5.07▼ | 5.20▼ | 5.20▼ | 5.17▼ | 4.53▲ |
| MA100 | 5.18▼ | 5.17▼ | 5.20▼ | 5.41▼ | 5.19▼ |
| MA200 | 5.14▼ | 5.10▼ | 5.21▼ | 4.68▲ | 5.97▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.001▲ | 0.003▲ | -0.008▼ | -0.085▼ |
| RSI | 41.507▼ | 41.453▼ | 41.578▼ | 44.881▼ | 49.355▼ |
| STOCH | 54.301 | 50.236 | 44.388 | 15.748▼ | 37.968 |
| WILL %R | -87.097▼ | -90.244▼ | -90.244▼ | -88.462▼ | -66.790 |
| CCI | -59.155 | -66.667 | -66.667 | -94.386 | -61.879 |
|
Monday, August 26, 2019 05:13 AM
SAN DIEGO, Aug. 26, 2019 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) ("Evofem" or the "Company") today announced the last patient has completed her last visit in AMPREVENCE, the Phase 2b ...
|
|
Friday, August 16, 2019 09:14 AM
In most cases, we still see only technical improvements to traditional products. Evofem BioSciences (NASDAQ:EVFM), with its unique product, brings a novel approach to the traditional market. I had ...
|
|
Tuesday, April 23, 2019 05:33 AM
Evofem Biosciences (NASDAQ:EVFM) has completed patient enrollment in AMPREVENCE, the Phase 2b clinical trial evaluating Amphora, a Multipurpose Vaginal pH Regulator (MVP-R), for the prevention of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/10/19 | 4.99 | 4.995 | 4.99 | 4.995 | 7,685 |
| 16/10/19 | 5.00 | 5.134 | 4.95 | 5.01 | 13,700 |
| 15/10/19 | 5.00 | 5.05 | 4.97 | 4.98 | 13,500 |
| 14/10/19 | 5.04 | 5.10 | 5.01 | 5.04 | 10,100 |
| 11/10/19 | 4.96 | 5.23 | 4.957 | 5.08 | 19,400 |
| 10/10/19 | 5.01 | 5.035 | 4.95 | 4.95 | 7,700 |
| 09/10/19 | 5.05 | 5.10 | 4.97 | 5.00 | 21,600 |
| 08/10/19 | 5.04 | 5.104 | 4.98 | 5.00 | 19,900 |
| 07/10/19 | 5.20 | 5.25 | 5.05 | 5.06 | 20,100 |
| 04/10/19 | 5.34 | 5.34 | 5.09 | 5.15 | 3,487 |
|
|
||||
|
|
||||
|
|